A spotlight on pathogenesis, interactions and novel therapeutic options in NAFLD

A spotlight on pathogenesis, interactions and novel therapeutic options in NAFLD, Published online: 17 December 2018; doi:10.1038/s41575-018-0094-6

In 2018, there have been substantial advances in our understanding of the risk factors for advanced liver disease in nonalcoholic fatty liver disease, including genetic variants and the gut microbiota. Promising results have also arisen from drugs targeting metabolic pathways involved in the progression of liver damage.

中文翻译：

---

聚焦于NAFLD的发病机理，相互作用和新的治疗选择

聚焦于NAFLD的发病机理，相互作用和新的治疗选择

在线发表：2018年12月17日，NAFLD的发病机理，相互作用和新的治疗选择的聚焦; doi：10.1038 / s41575-018-0094-6

在2018年，我们对非酒精性脂肪肝疾病中晚期肝病危险因素的理解有了重大进展，包括遗传变异和肠道菌群。靶向肝损伤进展中涉及的代谢途径的药物也产生了可喜的结果。